Zhongxin Finance, March 23 (Reporter Zhang Ni) A few days ago, the National Medical Insurance Bureau issued a "Notice", clarifying that each provincial medical insurance department should temporarily incorporate the new coronavirus antigen detection reagents and corresponding testing items into the basic medical insurance of the province according to procedures. Service Project Directory.
Zhongxin Finance noticed that many provinces, including Tianjin, Yunnan, Henan, Chongqing, etc., have clarified the upper limit of testing fees.
In addition, antigen detection reagents will also be included in the collection.
Data map: Photo by Liu Honghe of the antigen detection reagent production line
New coronavirus antigen test temporarily included in medical insurance
The Office of the National Medical Insurance Bureau issued the "Notice on Effectively Doing a Good Job in the Current Epidemic Prevention and Control Medical Insurance" on the 21st, clarifying that the relevant expenses incurred by the insured in the designated primary medical institutions shall be paid in accordance with the current regulations of the overall planning area, and the new crown virus is purchased in designated retail pharmacies. The cost of antigen detection reagents can be paid using a personal account.
In addition, the provincial medical insurance departments should adjust and optimize the medical security policies and measures for epidemic prevention and control in a timely manner, temporarily incorporate the novel coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items in their provinces according to procedures, and continue to standardize and optimize public medical institutions. Pricing policy for providing COVID-19 antigen testing services.
The above notice also clarifies that to support the normal operation of medical institutions in severely affected areas, part of the new crown treatment funds can be prepaid according to the procedures if necessary.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment.
It is clear in many places that the standard test reagents will be included in the collection
Zhongxin Finance has noticed that recently, the medical insurance departments in many places have clarified the charging standards for antigen testing.
For example, recently, the Tianjin Municipal Medical Insurance Bureau website issued a "Notice", which clarified that the government's guide price for the temporary new "novel coronavirus antigen test" project is 5 yuan per time, requiring public medical institutions to not increase the fees and to limit the reduction.
The "Notice" also clarifies that public medical institutions carry out "zero mark-up" for new coronavirus antigen detection reagents (including sampling equipment, the same below), and purchase them on the Tianjin Pharmaceutical Purchasing Platform as required, and eliminate offline purchases, with a maximum price limit of 9 yuan /share.
Non-public medical institutions and third-party testing institutions provide antigen testing services, and the pricing should follow the principles of "fairness, legality, and good faith", reflecting the preservation of capital and meager profits.
In addition, Yunnan, Henan, Chongqing and other provinces have also made it clear that the total cost of the new coronavirus antigen test is capped at 15 yuan per time.
Henan and Chongqing proposed that public medical institutions will exempt outpatient examination fees for people who simply test for antigens; public medical institutions are not allowed to charge price policies such as the cost of "novel coronavirus antigen detection" items for patients who test themselves.
In addition, antigen detection reagents will also be included in the collection.
Yunnan has made it clear that in order to cooperate with the implementation of the new coronavirus antigen detection price policy, the province has joined hands with relevant provinces to negotiate with new coronavirus antigen detection reagent manufacturers. On the centralized drug procurement platform, the online price of new coronavirus antigen detection reagents will be synchronized. From 16.8 yuan / person to 9.8 yuan / person.
In the next step, as the number of new coronavirus antigen detection reagents approved for the market continues to increase, the Yunnan Provincial Medical Security Bureau will also increase centralized procurement, further reduce the price of new coronavirus antigen detection reagents, and continue to reduce the burden on the masses.
Data from the State Food and Drug Administration shows that as of March 18, the State Food and Drug Administration has approved 17 new coronavirus antigen detection reagent products.
(over)